The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.

Strong Operating Cash Flow and Reduction in Debt; Positioned to Pivot to Growth in Back HalfExploring Strategic Options for Personal Care Category HOBOKEN, N.J., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Hain ...

Strong Operating Cash Flow and Reduction in Debt; Positioned to Pivot to Growth in Back HalfExploring Strategic Options for Personal Care ...

If phantom income is not properly analyzed by counsel and the court in a matrimonial case, the result perforce may be ...

Palantir's growth is of extremely high quality, showcasing accelerating growth. Click here to read why I keep a Hold rating ...

Q4 2024 Earnings Call Transcript February 6, 2025 Zimmer Biomet Holdings, Inc. beats earnings expectations. Reported EPS is ...

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could ...

To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach ...

An analysis of ASML's recent earnings report, focusing on orders and guidance, and discussing the impact of DeepSeek on the ...

Hess' track record for efficiently allocating capital and generating value has been steadily improving. The company has streamlined its portfolio by jettisoning less competitive and riskier positions ...

Church & Dwight Co., Inc. (NYSE: CHD) today announced the Company exceeded its outlook with stronger than expected sales growth. Full year 2024 net sales increased 4.1% to $6,107.1 million, ahead of ...

Greetings. Welcome to Dynatrace Fiscal third quarter 2025 earnings call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce Noelle Faris, Vice ...